KRYS - Krystal Biotech: VYJUVEK revenue has topped $1.1B since launch.
So what
VYJUVEK revenue rose 30% to $127.3M, but diluted EPS fell to $2.05 from $2.66.
Full-size download: part of Free Access (free). The sheet above stays free to view and share.
Free Access
One free signup opens full-size downloads of every sheet and the pre-earnings pack for each earnings week. No newsletter schedule to sign up for.
Free Access is on: full-size downloads and the pre-earnings pack are open.